We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+10.72%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.85B
AUM Growth
+$338M
Cap. Flow
+$79.4M
Cap. Flow %
1.36%
Top 10 Hldgs %
45.51%
Holding
707
New
76
Increased
198
Reduced
354
Closed
64

Top Buys

Rank Stock Value
1
TER icon
Teradyne
TER
+$60.1M
2
TSLA icon
Tesla
TSLA
+$32.1M
3
TSEM icon
Tower Semiconductor
TSEM
+$29.6M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$29M
5
PDD icon
Pinduoduo
PDD
+$28.1M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$77.7M
2
BE icon
Bloom Energy
BE
+$53.1M
3
HOOD icon
Robinhood
HOOD
+$24.9M
4
SAP icon
SAP
SAP
+$24.1M
5
BIDU icon
Baidu
BIDU
+$21.5M

Sector Composition

Rank Sector Weight
1 Technology 51.21%
2 Communication Services 15.38%
3 Consumer Discretionary 13.01%
4 Healthcare 6.62%
5 Consumer Staples 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANAB icon
476
AnaptysBio
ANAB
$1.58B
$26.3K ﹤0.01%
543
-59
-10% -$2.3K
LTC
477
LTC Properties
LTC
$2.06B
$26.2K ﹤0.01%
763
-26
-3% -$916
AMLX icon
478
Amylyx Pharmaceuticals
AMLX
$2.26B
$26.1K ﹤0.01%
2,158
+240
+13% +$3.26K
DFTX
479
Definium Therapeutics
DFTX
$5.78B
$25.9K ﹤0.01%
1,935
+298
+18% +$3.69K
XERS icon
480
Xeris Biopharma Holdings
XERS
$1.39B
$25.6K ﹤0.01%
3,260
-214
-6% -$1.68K
ELME
481
Elme Communities
ELME
$143M
$25.4K ﹤0.01%
1,461
-19
-1% -$322
ALEX
482
DELISTED
Alexander & Baldwin
ALEX
$24.9K ﹤0.01%
1,206
-6
-0.5% -$104
SEPN
483
Septerna Inc
SEPN
$1.55B
$24.5K ﹤0.01%
+878
New +$21K
NTST
484
NETSTREIT Corp
NTST
$2.09B
$24.4K ﹤0.01%
1,383
+29
+2% +$528
GTY
485
Getty Realty Corp
GTY
$2.11B
$24.4K ﹤0.01%
891
+11
+1% +$304
AMPH icon
486
Amphastar Pharmaceuticals
AMPH
$879M
$24.2K ﹤0.01%
902
-98
-10% -$2.52K
SVRA icon
487
Savara
SVRA
$1.12B
$24.1K ﹤0.01%
3,998
+331
+9% +$1.62K
OMER icon
488
Omeros
OMER
$857M
$23.9K ﹤0.01%
1,392
-72
-5% -$620
TNGX icon
489
Tango Therapeutics
TNGX
$4.43B
$23.4K ﹤0.01%
2,646
+252
+11% +$2.17K
PHAT icon
490
Phathom Pharmaceuticals
PHAT
$708M
$23.2K ﹤0.01%
1,397
-129
-8% -$1.84K
SPRY icon
491
ARS Pharmaceuticals
SPRY
$509M
$22.6K ﹤0.01%
1,942
-184
-9% -$1.79K
INBX icon
492
Inhibrx
INBX
$1.2B
$22.5K ﹤0.01%
285
-22
-7% -$1.5K
XHR
493
Xenia Hotels & Resorts
XHR
$1.9B
$22.4K ﹤0.01%
1,587
-71
-4% -$968
GRFS
494
Grifois
GRFS
$5.36B
$22.4K ﹤0.01%
2,396
-209
-8% -$1.9K
PEB icon
495
Pebblebrook Hotel Trust
PEB
$2.15B
$22.4K ﹤0.01%
1,977
-10
-0.5% -$110
CSTL icon
496
Castle Biosciences
CSTL
$855M
$22.3K ﹤0.01%
573
-51
-8% -$1.64K
IIPR icon
497
Innovative Industrial Properties
IIPR
$1.71B
$22K ﹤0.01%
464
+2
+0.4% +$104
PCRX icon
498
Pacira BioSciences
PCRX
$1.04B
$21.8K ﹤0.01%
844
-123
-13% -$2.92K
URGN icon
499
UroGen Pharma
URGN
$1.86B
$21.5K ﹤0.01%
919
-76
-8% -$1.65K
XNCR icon
500
Xencor
XNCR
$1.5B
$21.5K ﹤0.01%
1,402
-132
-9% -$1.97K
18 19
20
21 22

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GF Fund Management's Q4 2025 Portfolio in Review

As of Q4 2025, GF Fund Management held 707 positions worth $5.85B, up 6.1% from $5.51B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GF Fund Management's Q4 2025 filing shows 76 new, 198 increased, 354 reduced and 64 closed positions. Its largest new stake was Teradyne: 350,137 shares worth $67.8M. The largest sale was Broadcom, an estimated $77.7M.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 49% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q4 2025 buy was Teradyne: 350,137 shares worth $67.8M.
  • GF Fund Management added most to Tesla in Q4 2025, an estimated $32.1M increase.
  • GF Fund Management's biggest Q4 2025 reduction was Broadcom, cutting an estimated $77.7M.
  • GF Fund Management fully exited Baidu in Q4 2025, selling an estimated $21.5M.
  • GF Fund Management's ten largest holdings make up 46% of its $5.85B portfolio in Q4 2025.
  • GF Fund Management opened 76 new positions and closed 64 in Q4 2025.
  • GF Fund Management's portfolio value rose 6.1% quarter-over-quarter to $5.85B.

Based on GF Fund Management's 13F filing for Q4 2025, filed 27 Jan 2026.